Clinical Trial Update: Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on treating sinonasal malignancies using intensity-modulated radiotherapy with a carbon ion boost (C12).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Paranasal Sinuses
• Sinonasal Malignancies
• Squamous Cell Carcinoma of the Paranasal Sinuses

Snippet

Sponsor: Heidelberg University | Conditions: Sinonasal Malignancies, Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses | Phase 2 | Status: COMPLETED